A Cannabis Act expected to be in place by next summer in Canada will eventually open the market to hemp-based nutraceutical products, Australia-based Creso Pharma noted in a recent statement.
Creso Pharma stakes a claim in Canada
Latest from HT Premium
- August 21, 2018 | Cash and stock deal for Polish hemp firm: $15.5 million
- August 14, 2018 | Asian edge in the ‘New Green Revolution’: Genetic diversity
- August 13, 2018 | GW Pharma releases pricing on newly approved CBD-drug
- August 6, 2018 | ”Democratization of knowledge” will drive demand and data about medical cannabis
- July 30, 2018 | Reps from 10 countries will talk CBD at HT’s August biz meet-up